Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL.

Ding, Wei; LaPlant, Betsy R; Call, Timothy G; Parikh, Sameer A; Leis, Jose F; He, Rong; Shanafelt, Tait D; Sinha, Sutapa; Le-Rademacher, Jennifer; Feldman, Andrew L; Habermann, Thomas M; Witzig, Thomas E; Wiseman, Gregory A; Lin, Yi; Asmus, Erik; Nowakowski, Grzegorz S; Conte, Michael J; Bowen, Deborah A; Aitken, Casey N; Van Dyke, Daniel L; Greipp, Patricia T; Liu, Xin; Wu, Xiaosheng; Zhang, Henan; Secreto, Charla R; Tian, Shulan; Braggio, Esteban; Wellik, Linda E; Micallef, Ivana; Viswanatha, David S; Yan, Huihuang; Chanan-Khan, Asher A; Kay, Neil E; Dong, Haidong; Ansell, Stephen M.
Blood; 129(26): 3419-3427, 2017 06 29.
Artigo em Inglês | MEDLINE | ID: mdl-28424162